Excaliard Pharmaceuticals, Inc.;Northwestern University;Ionis Pharmaceuticals, Inc.
发明人:
申请号：
EP09812035.5
公开号：
EP2334319B1
申请日:
2009.08.26
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
This invention provides a method for reducing hypertropic scarring resulting from dermal wound healing in a subject in need which comprises administering to the subject an antisense oligonucleotide which inhibits expression of connective tissue growth factor (CTGF) in an amount effective to inhibit expression of CTGF and thereby reduce hypertrophic scarring.
